title: Evidence for rCBV as an early response marker following bevacizumab treatment.
authors.affiliation: University of California, Los Angeles, California.
authors.forename: Whitney B
authors.initials: WB
authors.lastname: Pope
mesh_terms: D020533:Angiogenesis Inhibitors / Q000627:therapeutic use*; D000068258:Bevacizumab / Q000627:therapeutic use*; D001932:Brain Neoplasms / Q000175:diagnosis* / Q000188:drug therapy*; D002540:Cerebral Cortex / Q000098:blood supply*; D005260:Female; D005909:Glioblastoma / Q000175:diagnosis* / Q000188:drug therapy*; D006801:Humans; D008279:Magnetic Resonance Imaging / Q000379:methods*; D008297:Male
chemical_list: D020533:Angiogenesis Inhibitors; D000068258:Bevacizumab